The Enterprise Value as of December 2025 (TTM) for Pacific Biosciences of California, Inc. (PACB) is 1.40B

According to Pacific Biosciences of California, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.40B. This represents a change of 34.68% compared to the average of 1.04B of the last 4 quarters.

Pacific Biosciences of California, Inc. (PACB) Historical Enterprise Value (quarterly & annually)

How has PACB Enterprise Value performed in the past?

The mean historical Enterprise Value of Pacific Biosciences of California, Inc. over the last ten years is 1.90B. The current 1.40B Enterprise Value has changed 7.29% with respect to the historical average. Over the past ten years (40 quarters), PACB's Enterprise Value was at its highest in in the June 2021 quarter at 7.30B. The Enterprise Value was at its lowest in in the March 2018 quarter at 242.14M.

Pacific Biosciences of California, Inc. (PACB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pacific Biosciences of California, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pacific Biosciences of California, Inc. (PACB) Average Enterprise Value

How has PACB Enterprise Value performed in the past?

The current Enterprise Value of Pacific Biosciences of California, Inc. (PACB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Pacific Biosciences of California, Inc. (PACB) Enterprise Value vs. Peers

How is PACB’s Enterprise Value compared to its peers?

Pacific Biosciences of California, Inc.’s Enterprise Value is greater than Avanos Medical, Inc. (579.77M), greater than Orthofix Medical Inc. (742.05M), greater than SI-BONE, Inc. (837.59M), greater than Butterfly Network, Inc. (647.13M), greater than DarioHealth Corp. (113.20M), greater than Iovance Biotherapeutics, Inc. (650.41M), greater than Integra LifeSciences Holdings Corporation (1.04B), greater than Fulgent Genetics, Inc. (751.52M), greater than Ginkgo Bioworks Holdings, Inc. (815.10M), less than POMDOCTOR Ltd (4.02B),

Build a custom stock screener for Pacific Biosciences of California, Inc. (PACB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pacific Biosciences of California, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pacific Biosciences of California, Inc. (PACB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pacific Biosciences of California, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.